Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Medtronic (NYSE:MDT). "I like what they’re doing in AI. You’ve got a good one with a good yield," he noted.
On March 27, the FDA approved Medtronic’s Evolut FX+ transcatheter aortic valve replacement (TAVR) system for symptomatic severe aortic stenosis. The latest Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate coronary access.
Riley Exploration Permian, Inc. (NYSE:REPX) is actually a very cheap stock, and it has got a good yield. "I don’t understand why it’s here, and I think you should buy it," he added.
On April 4, Riley Permian announced pricing of public offering of $18.9 million common stock at $27.00 per share.
The "Mad Money" host recommended buying WESCO International, Inc. (NYSE:WCC).
On April 1, Wesco International said it has completed the sale of its Wesco Integrated Supply business to Vallen Distribution, Inc for a purchase price of $350 million.
When asked about Cleveland-Cliffs Inc. (NYSE:CLF), he said, "I would buy that stock under 20, that’s my level."
On April 9, Wolfe Research downgraded Cleveland-Cliffs from Peer Perform to Underperform.
Read Next: Citizens And 2 Other Stocks Under $3 Insiders Are Buying
Image: Shutterstock